CFR Pharmaceutical, which tried for months to buy South Africa's Adcock Ingram, will now be gobbled up itself. Abbott will boost its now limited drug portfolio with a deal to buy the South American company for about $3 billion.
written on 16.05.2014
Abbott picks off Chile's CFR for $3B
